Home > Balance Sheet > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Total Non-Current Liabilities ₹12 Cr₹10.00 Cr₹8.66 Cr₹7.76 Cr₹7.73 Cr

What is the latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Total Non-Current Liabilities ratio of SYNCOM FORMULATIONS (INDIA) is ₹12 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹12 Cr
Mar2024₹10.00 Cr
Mar2023₹8.66 Cr
Mar2022₹7.76 Cr
Mar2017₹7.73 Cr

How is Total Non-Current Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹12 Cr
18.16
Mar2024 ₹10.00 Cr
15.49
Mar2023 ₹8.66 Cr
11.53
Mar2022 ₹7.76 Cr
0.36
Mar2017 ₹7.73 Cr -

Compare Total Non-Current Liabilities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,233.3 Cr -3.2% 7.5% -25.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-3.2%

7.5%

-25.4%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses